leqephe

litaba

Lilemong tsa morao tjena, indasteri ea malapeng ea in vitro diagnosis (IVD) e hotse ka potlako.Ho latela lintlha tse lokollotsoeng ke Evaluate MedTech, ho tloha 2014 ho isa 2017, sekhahla sa thekiso ea 'maraka oa lefats'e oa indasteri ea IVD se eketsehile selemo le selemo, ho tloha ho $49 bilione 900 ka 2014 ho ea ho $52 billion 600 million ka 2017, ka sekhahla sa kholo ea selemo le selemo ea kholo e kopaneng. 1.8%;ka 2024, tekanyo ea thekiso ea 'maraka e lebeletsoe ho fihla ho $ 79 limilione tse likete tse 600, ho tloha 2017 ho ea ho 2024 Sekhahla sa kholo ea selemo le selemo se fihlile ho 6,1%.Boemong bona, litlhoko tse ntseng li eketseha tsa kliniki le litekanyetso tsa ts'ebeliso ea indasteri le tsona li beha litlhoko tse ncha bakeng sa lihlahisoa le mahlale a IVD.Ka mor'a lilemo tse leshome tsa tsoelo-pele e ikemetseng ea "Lica light-induced chemiluminescence technology", e le mokhoa o mocha oa immunoassay oa chemiluminescent, Kemei hlahloba ka boqhetseke e amohela tsamaiso ea homogeneous reaction le nano high-tech particles, e fana ka tharollo e ncha bakeng sa lilaboratori tse ngata tsa kliniki.Ho ea ka boitsebiso ba sechaba, tšimong ea chemiluminescence immunodiagnosis Chaena, liphello tse ntle tsa sebaka sa heno li fihletsoe tšimong ea immunodiagnosis e bohareng le e tlaase.Leha ho le joalo, 'marakeng oa China oa maemo a holimo oa chemiluminescence, bahlahisi ba tsoang kantle ho naha ba ntse ba nka karolo e fetang 80% ea karolo ea mmaraka.Har'a bona, Abbott, Roche, Beckman le Siemens ba etsa karolo ea 70% ea karolo ea 'maraka.Leha ho le joalo, ka ntlafatso ea boemo ba ts'ebeliso ea meriana ea Chaena, khothatso ea phetoho ea tsamaiso ea bongaka, le tšehetso e matla ea maano a naha a indasteri, re ntse re shebane le nts'etsopele ea li-reagents tsa in vitro, 'me re tšepa ho sebelisana le uena.

3

Nako ea poso: Dec-24-2020